| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | C9orf26 ELISA Kit; CHROMOSOME 9 OPEN READING FRAME 26 ELISA Kit; DKFZp586H0523 ELISA Kit; DVS27 ELISA Kit; DVS27 related protein ELISA Kit; IL 1F11 ELISA Kit; IL 33 ELISA Kit; IL-1F11 ELISA Kit; IL-33 ELISA Kit; IL1F11 ELISA Kit; IL33 ELISA Kit; IL33_HUMAN ELISA Kit; Interleukin 1 family member 11 ELISA Kit; Interleukin 33 ELISA Kit; INTERLEUKIN 33 NFHEV ELISA Kit; Interleukin 33 precursor ELISA Kit; Interleukin-1 family member 11 ELISA Kit; Interleukin-33 (109-270) ELISA Kit; Interleukin33 ELISA Kit; NF HEV ELISA Kit; NF-HEV ELISA Kit; NFEHEV ELISA Kit; NFHEV ELISA Kit; Nuclear factor for high endothelial venules ELISA Kit; Nuclear factor from high endothelial venules ELISA Kit; OTTHUMP00000021041 ELISA Kit; RP11 575C20.2 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, urine |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Interleukin 33(IL-33) (IL33) is a biological molecule commonly studied in immunology research. It is commonly discussed as part of cytokine signaling that coordinates immune and inflammatory responses.
UniProt: O95760
Biological context
Researchers often monitor Interleukin 33(IL-33) in serum, plasma, and urine to better understand themes such as innate and adaptive immune responses, cytokine signaling networks, and host–pathogen interactions. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Interleukin 33(IL-33) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cytokines, chemokines, acute-phase proteins, and immune-cell activation markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Interleukin 33(IL-33) may also appear under names such as C9orf26 and CHROMOSOME 9 OPEN READING FRAME 26. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Interleukin 33(IL-33) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
РОЛЬ ИНФЕКЦИОННЫХ И СТЕРИЛЬНЫХ ВОСПАЛИТЕЛЬНЫХ ПРОЦЕСОВ У ЖЕНЩИН С ВЫКИДЫШАМИ НА РАННИХ СТАДИЯХ БЕРЕМЕННОСТИ
КО Мухитдинова, ВА Алейник, СМ Бабич,Журналтеоретическойиклиническоймедицины,/
Особенности цитокиновой продукции у пациентов с бактериальной пневмонией, протекающей на фоне острой респираторной вирусной инфекции
ВК Парфенюк, НВ Бондарь,Российский медико-биологический вестник имени академика ИП Павлова,2025
Cytokines assets in PLWH in two-drug dolutergravir based or three-drug antiretroviral regimen
K Falasca,BMC Infectious Diseases,2024
Soluble suppression of tumourigenicity 2 as a predictor of postoperative hepatic failure
J Wu,BJS open,2024
Associations of MEFV gene variants, IL-33, and sST2 with the risk of Henoch-Schönlein purpura in children
Y Ruan,Heliyon,2024
Reduced NK Cell Cytotoxicity by Papillomatosis-Derived TGF-β Contributing to Low-Risk HPV Persistence in JORRP Patients
X Wu,Frontiers in immunology,2023
Cytokines Profile and Lung Function in Children with Obesity and Asthma: A Case Control Study
L Maffeis,Children,2022
The Interleukin-33/ST2 Axis Enhances Lung-Resident CD14+ Monocyte Function in Patients with Non-Small Cell Lung Cancer
L Wang,Immunological Investigations,2022
Interleukin-32, interleukin-33 and acid phosphatase levels in patients with Helicobacter Pylori
KIA Mohammed,Researchgate,2022
Higher serum PGE2 is a predicative biomarker for postoperative delirium following elective orthopedic surgery in elderly patients
M Mao,BMC geriatrics,2022
Elevated DLL3 in stomach cancer by tumor-associated macrophages enhances cancer-cell proliferation and cytokine secretion of macrophages
JB Ye,Gastroenterology Report,2021
Relationship between interleukin 33 and tissue factor in non-diabetic and diabetic obese patients
C CAKICI,Acta Pharmaceutica Sciencia,2021
Assessment of TSLP, IL 25 and IL 33 in patients with shrimp allergy
N Ukleja-Sokołowska,Allergy Asthma Clin Immunol,2021
Role of interleukin 25 and interleukin 33 as immunological markers in pediatric asthma
ATN AL-Hasnawi,Eurasian Journal of Biosciences,2020
IL-33/ST2 Signaling Promotes TF Expression by Regulating NF-κB Activation in Coronary Artery Endothelial Microparticles of Acute Myocardial Infarction
Y Yuan,Research Square,2020
Interaction of Alt a 1 with SLC22A17 in the airway mucosa
Garrido-Arandia M,Allergy,2019